Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET

Rhea-AI Summary

Akili, Inc. (NASDAQ: AKLI) will conduct a conference call and webcast to discuss its financial and operational results for Q1 2023 on May 11, 2023, at 4:30 p.m. ET. The event will be accessible via www.akiliinteractive.com under the Investor Relations section. Investors can join by calling 888-575-5163 (toll-free) or 416-764-8620 (international), referencing “Akili Q1 2023 Earnings.” Akili is at the forefront of digital medicine, focusing on innovative cognitive treatments through engaging video game experiences, validated by clinical trials. Their unique platform aims to address cognitive impairments with enhanced user experiences.

Positive

• Innovative approach to cognitive treatments using engaging video game experiences.
• Products validated through rigorous clinical trials.
• Upcoming Q1 2023 earnings call could provide insights into company's performance.

Negative

• None.

BOSTON--(BUSINESS WIRE)-- Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its financial and operating results for the first quarter of 2023 on Thursday, May 11, 2023, at 4:30 p.m. ET.

A live audio webcast of the conference call and presentation will be available at www.akiliinteractive.com under Investor Relations, Events & Presentations. An archived version of the webcast will be available on the company’s website following the event.

To access the call, dial 888-575-5163 (toll-free) or 416-764-8620 (international) or and reference “Akili Q1 2023 Earnings.”

About Akili

Akili is pioneering the development of cognitive treatments through game-changing technologies. Our approach of leveraging technologies designed to directly target the brain establishes a new category of medicine – medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s products are delivered through captivating action video game experiences. For more information, please visit www.akiliinteractive.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230413005498/en/

Santosh Shanbhag

Chief Financial Officer

InvestorRelations@akiliinteractive.com

Julie DiCarlo

SVP, Communications

PR@akiliinteractive.com

Source: Akili, Inc.

FAQ

When is Akili's Q1 2023 earnings call?

Akili's Q1 2023 earnings call is scheduled for May 11, 2023, at 4:30 p.m. ET.

How can I access Akili's earnings call?

You can access Akili's earnings call by calling 888-575-5163 (toll-free) or 416-764-8620 (international), or through a webcast at www.akiliinteractive.com.

What is the focus of Akili's business?

Akili focuses on developing cognitive treatments through digital medicine, utilizing engaging video game formats that are validated by clinical trials.

What stock symbol does Akili operate under?

Akili operates under the stock symbol 'AKLI' on NASDAQ.